Filings
| Filing | Date | Type | Filed with |
|---|
| (688321)"Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Initial Repurchase of Shares through Call Auction | Nov 18, 2026 | Other filings | Shanghai Stock Exchange |
|---|
| (688321)"Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Not Revising the Conversion Price of "Chipscreen Convertible Bonds" Downward | Nov 17, 2026 | Financing | Shanghai Stock Exchange |
|---|
| (688321)"Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Voluntary Disclosure of the Renewed Inclusion of the Company's Product in the National Reimbursement Drug List | Nov 16, 2026 | Other filings | Shanghai Stock Exchange |
|---|
| (688321)"Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Voluntary Disclosure of Acceptance of Clinical Trial Application for CS231295 Tablets | Nov 14, 2026 | Operations update | Shanghai Stock Exchange |
|---|
| (688321)"Shenzhen Chipscreen Biosciences Co., Ltd."Indicative Announcement on "Chipscreen Convertible Bonds" Expected to Meet Conditions for Revising Conversion Price | Nov 10, 2026 | Financing | Shanghai Stock Exchange |
|---|
| (688321)"Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Shareholdings of Top 10 Shareholders and Top 10 Shareholders Holding Unrestricted Shares Concerning Share Repurchase | Nov 10, 2026 | Other filings | Shanghai Stock Exchange |
|---|
| (688321)"Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Share Repurchase Proposal through Call Auction and Receipt of Commitment Letter for Special Loan for Share Repurchase from Financial Institution | Nov 6, 2026 | Other filings | Shanghai Stock Exchange |
|---|
| (688321)"Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Resolutions of the 32nd Meeting of the 3rd Board of Directors | Nov 6, 2026 | Meeting outcome | Shanghai Stock Exchange |
|---|
| (688321)"Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Proposal from the Chairman for Share Repurchase | Oct 30, 2026 | Other filings | Shanghai Stock Exchange |
|---|
| (688321)"Shenzhen Chipscreen Biosciences Co., Ltd."Report for Q3 2026 | Oct 28, 2026 | Quarterly report | Shanghai Stock Exchange |
|---|
| (688321)"Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Signing of Project Cooperative Development Agreement and Related Party Transactions | Oct 22, 2026 | Material contract | Shanghai Stock Exchange |
|---|
| (688321)"Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Convening the Q3 2026 Performance Briefing | Oct 21, 2026 | Meeting notice | Shanghai Stock Exchange |
|---|
| (688321)"Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Voluntary Disclosure of Receipt of the Drug Clinical Trial Approval Notice for NW001 | Oct 17, 2026 | Operations update | Shanghai Stock Exchange |
|---|
| (688321)"Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Voluntary Disclosure of Acceptance of Clinical Trial Application for CS23546 Tablets | Oct 15, 2026 | Operations update | Shanghai Stock Exchange |
|---|
| (688321)"Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Voluntary Disclosure of Receipt of the Clinical Trial Approval Notice for CS43158 Tablets | Oct 13, 2026 | Operations update | Shanghai Stock Exchange |
|---|
| (688321)"Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Conversion Results of Convertible Bonds and Share Changes | Oct 9, 2026 | Operations update | Shanghai Stock Exchange |
|---|
| "Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Listing and Trading of Restricted Shares from 2024 Private Placement of Shares | Aug 25, 2026 | Financing | Shanghai Stock Exchange |
|---|
| "Shenzhen Chipscreen Biosciences Co., Ltd."Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026 | Aug 19, 2026 | Other filings | Shanghai Stock Exchange |
|---|
| "Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Convening the 2026 Semi-annual Performance Briefing | Aug 12, 2026 | Meeting notice | Shanghai Stock Exchange |
|---|
| "Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Voluntary Disclosure Regarding Acceptance of Clinical Trial Application for NW001 | Aug 5, 2026 | Operations update | Shanghai Stock Exchange |
|---|
| "Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Adjustment of Related Matters for the 2026 Restricted Share Incentive Plan | Aug 4, 2026 | Other filings | Shanghai Stock Exchange |
|---|
| "Shenzhen Chipscreen Biosciences Co., Ltd."Self-inspection Report on Trading in the Company's Shares by Insiders with Access to Inside Information in Relation to the 2026 Restricted Share Incentive Plan | Jul 31, 2026 | Legal or regulatory action | Shanghai Stock Exchange |
|---|
| "Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Voluntary Disclosure of Acceptance of Clinical Trial Application for CS43158 Tablets | Jul 30, 2026 | Operations update | Shanghai Stock Exchange |
|---|
| "Shenzhen Chipscreen Biosciences Co., Ltd."Review Opinion and Statement on the Public Disclosure of the List of Participants for the Initial Grant under the Company's 2026 Restricted Share Incentive Plan Issued by the Remuneration and Appraisal Committee of the Board of Directors | Jul 26, 2026 | Other filings | Shanghai Stock Exchange |
|---|
| "Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Implementation Result of Shares Repurchase and Share Changes | Jul 16, 2026 | Other filings | Shanghai Stock Exchange |
|---|
| "Shenzhen Chipscreen Biosciences Co., Ltd."Notice on Convening the 1st Extraordinary General Meeting in 2026 | Jul 15, 2026 | Meeting notice | Shanghai Stock Exchange |
|---|
| "Shenzhen Chipscreen Biosciences Co., Ltd."Announcement on Conversion Result of Convertible Bonds and Share Changes | Jul 1, 2026 | Financing | Shanghai Stock Exchange |
|---|
| Announcement on Follow-up Credit Rating Results of "Chipscreen Convertible Bonds" | Jun 26, 2026 | Financing | Shanghai Stock Exchange |
|---|
| Announcement on Progress in Repurchasing Shares | Jun 1, 2026 | Other filings | Shanghai Stock Exchange |
|---|
| Indicative Announcement on Report on Results of Shareholders' Inquiry Transfer and Equity Change of Shareholders with Over 5% Shares Reaching 5% Integer Multiple | May 22, 2026 | Other filings | Shanghai Stock Exchange |
|---|
| Indicative Announcement on Pricing for Shareholders' Inquiry-based Transfer | May 18, 2026 | Other filings | Shanghai Stock Exchange |
|---|
| Shareholders' Inquiry Transfer Plan | May 15, 2026 | Acquisition or disposal | Shanghai Stock Exchange |
|---|
| Announcement on Voluntary Disclosure of Approval of Chiglitazar Sodium for Market Release by the Pharmaceutical Administration Bureau, Macao SAR | May 14, 2026 | Operations update | Shanghai Stock Exchange |
|---|
| Announcement on Receipt of the "Decision on the Examination of an Invalidity Declaration Request" from the China National Intellectual Property Administration | May 8, 2026 | Legal or regulatory action | Shanghai Stock Exchange |
|---|
| Announcement on Adjusting the Conversion Price of "Chipscreen Convertible Bonds" Due to the Implementation of the 2025 Annual Profit Distribution and Resumption of Trading After Conversion Suspension | May 7, 2026 | Trading halt or suspension | Shanghai Stock Exchange |
|---|
| Announcement on Convening the Q1 2026 Performance Briefing | Apr 30, 2026 | Meeting notice | Shanghai Stock Exchange |
|---|
| Report for Q1 2026 | Apr 29, 2026 | Quarterly report | Shanghai Stock Exchange |
|---|
| Indicative Announcement on the Adjustment of Convertible Bond Conversion Prices and Continuous Suspension for Convertible Shares during the Implementation of 2025 Annual Dividend Distribution | Apr 28, 2026 | Trading halt or suspension | Shanghai Stock Exchange |
|---|
| Announcement on Resolutions of the 2025 Annual General Meeting | Apr 20, 2026 | Meeting outcome | Shanghai Stock Exchange |
|---|
| Announcement on Conversion Result of Convertible Bonds and Share Changes | Apr 1, 2026 | Operations update | Shanghai Stock Exchange |
|---|
| Announcement on Resolutions of the 25th Meeting of the 3rd Board of Directors | Mar 30, 2026 | Other filings | Shanghai Stock Exchange |
|---|
| Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Clinical Trials of Siglitazone Sodium and Metformin Hydrochloride Extended-Release Tablets | Mar 16, 2026 | Operations update | Shanghai Stock Exchange |
|---|
| Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Clinical Trials of CS08399 Tablets | Mar 13, 2026 | Other filings | Shanghai Stock Exchange |
|---|
| Announcement on Initially Repurchasing the Company's Shares through Call Auction | Mar 11, 2026 | Other filings | Shanghai Stock Exchange |
|---|
| Announcement on Obtaining Letter of Commitment for Special Loans for Stock Repurchase from Financial Institution | Mar 10, 2026 | Financing | Shanghai Stock Exchange |
|---|
| Announcement on Adjustment of the Conversion Price and Trading Suspension/Resumption of "Chipscreen Convertible Bonds" Due to Private Placement of Shares | Mar 3, 2026 | Trading halt or suspension | Shanghai Stock Exchange |
|---|
| Announcement on the Chairman's Proposal to Repurchase Shares | Feb 27, 2026 | Other filings | Shanghai Stock Exchange |
|---|
| Announcement on Preliminary Earnings Estimate for 2025 | Feb 26, 2026 | Results | Shanghai Stock Exchange |
|---|
| Announcement on Signing Tripartite Supervision Agreement for Deposit of Raised Fund in Special Account | Feb 25, 2026 | Other filings | Shanghai Stock Exchange |
|---|
| Announcement on Execution of a License and Distribution Agreement with Nizhpharm | Feb 3, 2026 | Other filings | Shanghai Stock Exchange |
|---|
| Announcement on the Thawing of Partially Frozen Shares Held by a Shareholder Owning 5% or More of the Company’s Equity | Jan 30, 2026 | Other filings | Shanghai Stock Exchange |
|---|
| Announcement on Proposed Participation of Connected Persons in the Subscription of Shares Issued to Specific Objects and Related Party Transaction | Jan 29, 2026 | Other filings | Shanghai Stock Exchange |
|---|
| Announcement on Earnings Preannouncement for 2025 | Jan 26, 2026 | Guidance | Shanghai Stock Exchange |
|---|
| Indicative Announcement on "Chipscreen Convertible Bonds" Expected to Meet Conditions for Redemption | Jan 22, 2026 | Financing | Shanghai Stock Exchange |
|---|
| Announcement on Estimated Amount of Daily Related Party Transactions in 2026 | Jan 15, 2026 | Other filings | Shanghai Stock Exchange |
|---|
| Prospectus for Issuance of A-shares to Specific Objects in 2024 (Registration Draft) | Jan 14, 2026 | Offer document | Shanghai Stock Exchange |
|---|
| Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Clinical Trials of Chiauranib Capsules | Jan 8, 2026 | Operations update | Shanghai Stock Exchange |
|---|
| Announcement on Voluntary Disclosure of Approval of Chidamide for Market Release by the Pharmaceutical Administration Bureau, Macao SAR | Jan 7, 2026 | Other filings | Shanghai Stock Exchange |
|---|
| Announcement on Voluntary Disclosure of Acceptance of the Clinical Trial Application for Chiglitazar Sodium Sustained-release Tablets | Jan 5, 2026 | Other filings | Shanghai Stock Exchange |
|---|
| Announcement on Voluntary Disclosure on the Acceptance of the Clinical Trial Application for CS08399 Tablets | Dec 31, 2025 | Other filings | Shanghai Stock Exchange |
|---|
| Announcement on Implementation Result of Shares Repurchase and Share Changes | Dec 23, 2025 | Results | Shanghai Stock Exchange |
|---|
| Announcement on Voluntary Disclosure of the Inclusion of the Company’s Product in the National Medical Insurance Catalog | Dec 7, 2025 | Other filings | Shanghai Stock Exchange |
|---|
| Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025 | Dec 5, 2025 | Meeting notice | Shanghai Stock Exchange |
|---|
| Announcement on Obtaining Reply of Registration Approval of Application for Issuance of Shares to Specific Objects from China Securities Regulatory Commission | Dec 2, 2025 | Financing | Shanghai Stock Exchange |
|---|
| Announcement on Equity Change of Shareholder with Over 5% Shares Reaching 1% Scale and Result of Shareholding Reduction | Nov 26, 2025 | Other filings | Shanghai Stock Exchange |
|---|
| Announcement on Resolutions of the 18th Meeting of the 3rd Board of Directors | Nov 19, 2025 | Meeting outcome | Shanghai Stock Exchange |
|---|
| Announcement on Voluntary Disclosure on the Acceptance of Clinical Trial Application for Chiauranib Capsules for Treatment of Metastatic Pancreatic Ductal Adenocarcinoma | Nov 6, 2025 | Operations update | Shanghai Stock Exchange |
|---|
| Announcement on Shareholding of Top 10 Shareholders and Top 10 Shareholders Without Sales Restrictions Concerning Share Repurchase | Nov 5, 2025 | Other filings | Shanghai Stock Exchange |
|---|
| Announcement on Non-compliance with Exercise Conditions in the 4th Exercise Period of 2021 Stock Appreciation Right Incentive Plan and Cancellation of This Part of Stock Appreciation Rights | Oct 31, 2025 | Other filings | Shanghai Stock Exchange |
|---|
| Report for Q3 2025 | Oct 30, 2025 | Other filings | Shanghai Stock Exchange |
|---|
| Announcement on Receiving Notice of Review Opinions from Shanghai Stock Exchange for Application for the Issuance of A-shares to Specific Objects in 2024 | Oct 29, 2025 | Other filings | Shanghai Stock Exchange |
|---|
| Announcement on Convening the Q3 2025 Performance Briefing | Oct 24, 2025 | Meeting notice | Shanghai Stock Exchange |
|---|
| Indicative Announcement on Equity Change of Shareholder with Over 5% Shares Reaching an Integral Multiple of 5% Scale | Oct 16, 2025 | Ownership change notice | Shanghai Stock Exchange |
|---|
| Indicative Announcement on Reply to Letter of Review and Inquiry on Application Documents for A-shares Issuance to Specific Objects in 2024 | Sep 24, 2025 | Other filings | Shanghai Stock Exchange |
|---|
| Special Report on the Use of Previously Raised Funds | Sep 15, 2025 | Other filings | Shanghai Stock Exchange |
|---|
| Announcement on Shareholding Reduction Plan for Shareholders with Over 5% Shares | Sep 10, 2025 | Other filings | Shanghai Stock Exchange |
|---|
| Announcement on Resignation of Senior Management Member | Sep 1, 2025 | Management or board change | Shanghai Stock Exchange |
|---|
| 2025 Semi-annual Report | Aug 25, 2025 | Interim report | Shanghai Stock Exchange |
|---|
| Announcement on Acceptance of Application for Issuance of A Shares to Specific Objects in 2024 by SSE | Aug 22, 2025 | Other filings | Shanghai Stock Exchange |
|---|
| Announcement on Continuing to Use Temporarily Idle Raised Funds for Cash Management | Aug 18, 2025 | Other filings | Shanghai Stock Exchange |
|---|
| Announcement on Convening the 2025 Semi-annual Performance Briefing | Aug 14, 2025 | Other filings | Shanghai Stock Exchange |
|---|
| Announcement on Voluntary Disclosure of Semi-annual Earnings Preannouncement for 2025 | Jul 17, 2025 | Other filings | Shanghai Stock Exchange |
|---|
| Announcement on Voluntary Disclosure of Top-line Analysis Data of Phase III Clinical Trial of Chidamide as the First-line Treatment for Diffuse Large B-cell Lymphoma | Jul 9, 2025 | Other filings | Shanghai Stock Exchange |
|---|
| Announcement on Abnormal Fluctuations in Stock Trading | Jul 3, 2025 | Other filings | Shanghai Stock Exchange |
|---|